45 kinds of rare diseases have been introduced into medical insurance, the 2021 version is expected to announce the end of the month

  "Incorporating more rescued a good medicine into the medical insurance catalog" is the main line of medical reform led by the National Medical Insurance Bureau.

Treatment of rare disease "orphan medicine", clinical lack of child medicines are the focus of the annual medical insurance catalog adjustment. In the past 11 years, the types of rare disease medications covered by the medical insurance catalog in my country have doubled, and more and more patients with rare diseases benefit. The variety, amount, etc. of children’s specialist hospitals, etc. have significantly increased in various medical insurance catalog adjustments. In the national medical insurance negotiations ended last week, the negotiations of rare diseased drugs were also a hot spot in market attention. During the period of the Expo, Huang Huapo, Director of the Ministry of Medicine, Medical Services, said that the drug directory adjustment focuses on the clinical value, reasonable price, better meets the introduction of basic medical needs, so that patients use new drugs faster, Good medicine.

  According to the practice of previous years, the National Medical Insurance Bureau will announce the new version of the medical insurance catalog for half a month after the medical insurance negotiation.

According to this year’s negotiation time, the 2021 medical insurance catalog is expected to announce the end of the moon. 45 kinds of rare diseased drugs have been incorporated into a rare pathogenesis, and rare diseased drugs have small demand, high cost, and less alternatives, and are often referred to as "orphan medicine." my country has issued a series of policies in the production and purchase reimbursement, which guarantees market supply and medical insurance support for orphans.

  Zhu Minglai, director of the Health Economic and Medical Security Research Center, Nankai University, said to the first financial advice, although the rare disease rate is not high, but the "high price medicine" exceeds the ability to pay for most people, once the masses are unfortunately suffering from rare diseases Help the situation, through negotiations and collects, cost the cost to reasonable price, play the advantages of medical insurance bands, which will greatly relieve the difficulties of special people.

  Recently, the China Medical Society Science and Technology Development Center released "China Medical Book" (hereinafter referred to as "Blue Book", a multi-dimensional data analysis of 804 sample hospitals since 2015 in 2015 .

According to the Blue Book, in recent years, the medical insurance catalog has improved the prevention of special populations such as rare diseases and patients with children.

  Data show that the 2009 version of the medical insurance catalog contains 22 rare diseases, covering 13 diseases, rare diseases; 2017 version of the medical insurance catalog contains rare diseases of 30 diseases, covering 15 rare diseases; 2019 version of the medical insurance catalog contains 39 A rare disease of rare diseases, covering 19 diseases; 2020 English medical insurance catalog contains 45 rare diseased medicines, covering 22 diseases rare diseases.

  More and more rare diseased medicines are incorporated into the medical insurance catalog, and the rare diseases are also significantly increased. After the relevant drugs were transferred to the medical insurance, the amount and the amount of dosage have increased significantly, and the treatment of patients with rare diseases was improved. The blue book showed that the amount of money used from rare diseases was incorporated into the medical insurance. In 2009, the amount of rare diseased medication in the medical insurance catalog has grown steadily, but the growth rate will decrease year by year; the 2017 version is transferred to the drug after the implementation One year, the amount growth rate is more than 100%, the amount of falling, the amount and the amount will remain a steady growth trend after one year; the 2019 version is transferred in recent years, the amount of amount of amount of amount is significantly increased, the amount of new corona epidemic in the first quarter of 2020 It can still maintain a high-speed growth trend. In September this year, the State Medical Insurance Bureau said in a letter to the No. 4468 of the 13th National Committee of the Political Consultative Conference. Currently, more than 40 rare diseases in China have been included in the national medical insurance drug catalog. In 2020, Ten Nimod, treating multiple sclerosis, treated the treatment of 丁 azine, treating the treatment of Titan’s disease (ALS), etc., the treatment of muscle atrophy, sodium chloride, etc. The diseased drug is included in the national medical insurance drug catalog, the price of drugs has declined, and the medical security level in patients with rare disease is significantly improved.

  Next, the National Medical Insurance Bureau will combine clinical treatment requirements, medical insurance funding capabilities, etc., will include the eligible rare diseases in accordance with the scope of the medical insurance payment, and further enhance the level of protection of rare diseases.

  Zhu Minglai believes that the basic principle of the National Medical Insurance Bureau is "widely covered, guaranteed", rare disease-free cost, and there are many need for lifelong medication, the treatment cost is very high, only the medical insurance fund is obviously unbearable, need to establish as soon as possible A package includes basic medical insurance, major illness, financial special fund, social assistance, etc. The lack of child clinical medication in children is also a big short board in my country’s pharmaceutical industry. In recent years, the State Food and Drug Administration has accelerated the examination and approval of children’s medication. The State Food and Drug Administration has ratified 13 children’s chemical drugs this year, filled some gaps in the treatment of drugs in domestic children; and also formulated relevant policies and technical guidelines, continuously improve the principle of children’s drug research and development guidelines, and promotes more Good child medicine accelerates it. Since 2000, the national medical insurance drug catalog has been adjusted six times. The number of drugs in the catalog increased from 1535 to 2,800, and the medical insurance catalog is also further expanded, and the child medication is in recent years in recent years. One of the highlights of adjustment. Blue books show that children’s specialist hospital samples, in the first quarter of 2015 to 2021, the number of varieties, amount proportional to the use of medical insurance drugs, the amount of amount, and dosage have significantly increased in various medical insurance catalog. With the steady advancement of dynamic adjustment of the national medical insurance catalog, more children can use drugs to be transferred to the medical insurance catalog, and their guarantee level is constantly improving.

  On the number of varieties of use, the number of medical insurance drug varieties is at a lower level in 2015 to 2017. Since 2018, after the implementation of the medical insurance catalog, the number of medical insurance drug varieties has increased significantly, accounting for% increase from the first quarter of 2015 to the first quarter of 2018. After the 2019 version of the medical insurance catalog, The number of medical insurance drug varieties increased to% in the first quarter of 2020. On the amount of the purchase, the overall use of medical insurance drugs in the Children’s Specialist Hospital showed a stable increase.

The implementation of the 2017 version of the medical insurance catalog, the amount of medical insurance drugs accounted for the total proportion of medicine rose to% in the first quarter of 2015, and then maintains a steady growth situation.

  In 2020, the National Medical Protection Bureau medical insurance catalog (2019 version) has carried out a new round of adjustment work, and the amount of medical insurance drug use is significantly improved, up to%.

  In the usual, the medical insurance drugs in the Children’s Specialist Hospital have increased significantly after the 2019 version of the medical insurance catalog, the amount ratio of the first quarter of 2020 is%, and the amount usage of the quarter is more than 75%.

  Blue books, the design and implementation of medical insurance policies, fully taking into account the use of drugs such as rare patients, children’s patients, more and more rare diseases, children can be included in medical insurance.